Predict your next investment

HEALTHCARE | Biotechnology
atterx.com

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$6.31M

Last Raised

$380K | 5 yrs ago

About Atterx Biotherapeutics

Developer of antibacterial technologies for the prevention and treatment of drug-resistant strains of pathogenic bacterial infections. The company's product uses bacterial interference technology to inhibit bladder infections in spinal cord injury patients and others with indwelling catheters. The active ingredient in the product has been previously tested in people for the prevention of urinary tract infections.

Atterx Biotherapeutics Headquarter Location

University Research Park 505 South Rosa Road, Suite 29

Madison, Wisconsin, 53719,

United States

(608)441-2794

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Atterx Biotherapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Atterx Biotherapeutics is included in 3 Expert Collections, including Infectious Disease.

I

Infectious Disease

2,330 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

M

Medical Devices

8,341 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Atterx Biotherapeutics Patents

Atterx Biotherapeutics has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/27/2015

4/28/2020

Food additives, Potassium compounds, Sugar substitutes, Acid fast bacilli, Nontuberculous mycobacteria

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/27/2015

00/00/0000

Grant Date

4/28/2020

00/00/0000

Title

Subscribe to see more

Related Topics

Food additives, Potassium compounds, Sugar substitutes, Acid fast bacilli, Nontuberculous mycobacteria

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.